ARN No Codificante Terapéutico, Microproteínas y Estrés Integrado en Cáncer
NONCOD
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Marqués de Valdecilla (12)
2024
-
Binge drinking at time of bariatric surgery is associated with liver disease, suicides, and increases long-term mortality
Hepatology Communications, Vol. 8, Núm. 8
2023
2022
-
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Gut, Vol. 71, Núm. 9, pp. 1856-1866
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
2021
-
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
JHEP Reports, Vol. 3, Núm. 3
-
Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases
BMC Medicine, Vol. 19, Núm. 1
2020
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
Scientific Reports, Vol. 10, Núm. 1
-
Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis
American Journal of Gastroenterology, Vol. 115, Núm. 3, pp. 398-405
2019
-
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis
Nature Communications, Vol. 10, Núm. 1
2017
-
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil
Liver Transplantation, Vol. 23, Núm. 4, pp. 498-509